Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential

Considering the cognitive impairment induced by temozolomide (TMZ) in glioblastoma survivors, the present study was aimed to evaluate the protective effect of dehydrozingerone (DHZ) against TMZ-induced cognitive impairment (chemobrain) and C6 cell line-induced glioma in male Wistar rats. In both che...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:3 Biotech
Autors principals: Pathak, Nandini, Cheruku, Sri Pragnya, Rao, Vanishree, Vibhavari, R. J. A., Sumalatha, Suhani, Gourishetti, Karthik, Rao, C. Mallikarjuna, Kumar, Nitesh
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://ncbi.nlm.nih.gov/pubmed/32995109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13205-020-02427-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars